Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Li-Fraumeni Syndrome 1Glioma 1Glioblastoma 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diffusion Magnetic Resonance Imaging × 1 year × Clear all
NCT03176836 2026-04-29

Li-Fraumeni Syndrome Imaging Study

The Hospital for Sick Children

Phase NA Enrolling by invitation
30 enrolled

Li-Fraumeni Syndrome

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting
20 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡